Table IV.
Severity of Most Common Adverse Effects
| Adverse Effect | No. of Completed Surveys | Months Reporting the Effect | % | P Value* |
|---|---|---|---|---|
| Muscle Aches/Pains | 729 | |||
| Mild | 116 | 15.91% | <0.001 | |
| Moderate | 41 | 5.62% | <0.001 | |
| Severe | 11 | 1.51% | <0.001 | |
| Dry Lips | 731 | |||
| Mild | 284 | 38.85% | <0.0001 | |
| Moderate | 301 | 41.18% | <0.0001 | |
| Severe | 104 | 14.23% | <0.0001 | |
| Dry Skin | 732 | |||
| Mild | 339 | 46.31% | <0.0001 | |
| Moderate | 154 | 21.04% | <0.0001 | |
| Severe | 35 | 4.78% | <0.0001 | |
| Dry/Bloodshot Eyes | 729 | |||
| Mild | 159 | 21.81% | <0.0001 | |
| Moderate | 49 | 6.72% | <0.0001 | |
| Severe | 7 | 0.96% | 0.0039 |
*
P values test whether “%” is statistically greater than zero.